title: Polymorphisms of angiotensin-converting enzyme and angiotensinogen genes in type 2 diabetic sibships in relation to albumin excretion rate.
abstract: Familial clustering of altered albumin excretion and nephropathy risk has been described in both type 1 and type 2 diabetes; moreover, an association of micro-macroalbuminuria and diabetic retinopathy has been recently reported in a large number of white families with type 2 diabetes. Conflicting reports, mainly comparing affected with unaffected unrelated subjects, have suggested a possible role of some genotypes of the renin-angiotensin system in conferring nephropathy risk in type 2 diabetes. To examine the role of genetic factors in influencing albuminuria in families, we studied the relation of angiotensin-converting enzymes (ACE) and angiotensinogen (AGN) genotypes with albumin excretion rate in a population of affected siblings of type 2 diabetic probands. We determined ACE insertion/deletion polymorphism and two polymorphisms of the AGN gene (T174M and M235T) in 160 families with at least one affected member. Defining proband as the patient with the longest known duration of diabetes, we compared the allelic distribution in diabetic probands with and without altered albumin excretion and in their siblings. Allelic distribution of these polymorphisms was similar in the two groups of probands, as well as in their siblings. Identity-by-State (IBS) analysis showed a link between AGN locus and arterial hypertension in these siblings, which was independent from the degree of renal involvement. Thus, our findings suggest that in white families with type 2 diabetes, there is no linkage between the degree of albumin excretion and ACE and AGN polymorphisms, whereas the latter is related to arterial hypertension, as previously found in patients without diabetes but with essential hypertension.
authors.affiliation: Department of Internal Medicine, University of Ferrara, Italy. sli@dns.unife.it
authors.forename: A
authors.initials: A
authors.lastname: Solini
authors.forename: G
authors.initials: G
authors.lastname: Giacchetti
authors.forename: A
authors.initials: A
authors.lastname: Sfriso
authors.forename: P
authors.initials: P
authors.lastname: Fioretto
authors.forename: C
authors.initials: C
authors.lastname: Sardu
authors.forename: A
authors.initials: A
authors.lastname: Saller
authors.forename: G
authors.initials: G
authors.lastname: Tonolo
authors.forename: M
authors.initials: M
authors.lastname: Maioli
authors.forename: F
authors.initials: F
authors.lastname: Mantero
authors.forename: R
authors.initials: R
authors.lastname: Nosadini
mesh_terms: D000419:Albuminuria / Q000235:genetics; D000483:Alleles; D000808:Angiotensinogen / Q000235:genetics*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000235:genetics* / Q000652:urine; D003928:Diabetic Nephropathies / Q000235:genetics / Q000652:urine; D003930:Diabetic Retinopathy / Q000235:genetics / Q000652:urine; D005260:Female; D008040:Genetic Linkage; D005838:Genotype; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000235:genetics; D007558:Italy; D008297:Male; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic
chemical_list: D000808:Angiotensinogen; D007703:Peptidyl-Dipeptidase A